Matthew Lorber
Child & Adolescent Psychiatry · New York, NYNPI 1730342726
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Axsome Therapeutics, Inc. accounts for 97.9% of it on its own, with 17 other manufacturers making up the rest. Among child & adolescent psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 612 payments — averaging $651.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$390K
- E.r. Squibb & Sons, L.L.C.$3K
- Corium, LLC$2K
- Otsuka America Pharmaceutical, Inc.$991
- Sunovion Pharmaceuticals Inc.$953
- Vanda Pharmaceuticals Inc.$251
- plus $1K from 12 others
What the payments were for
- Consulting fees$213,86554%
- Speaking & faculty fees$116,62129%
- Travel & lodging$50,10513%
- Food & beverage$17,8964%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 482 | $390,031 |
| E.r. Squibb & Sons, L.L.C. | 13 | $3,274 |
| Corium, LLC | 3 | $1,558 |
| Otsuka America Pharmaceutical, Inc. | 32 | $991 |
| Sunovion Pharmaceuticals Inc. | 33 | $953 |
| Vanda Pharmaceuticals Inc. | 8 | $251 |
| Teva Pharmaceuticals USA, Inc. | 3 | $241 |
| Banner Life Sciences, LLC | 14 | $196 |
| Nevro Corp. | 3 | $138 |
| Collegium Pharmaceutical, Inc. | 6 | $134 |
| Phathom Pharmaceuticals, Inc. | 1 | $128 |
| AbbVie | 1 | $125 |
| Nalu Medical, Inc. | 1 | $124 |
| Boston Scientific | 1 | $109 |
| Supernus Pharmaceuticals, Inc. | 4 | $92 |
| Lundbeck LLC | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Adlon Therapeutics L.p. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$382,443
- COBENFY$3,077
- Azstarys$1,558
- REXULTI$375
- VOQUEZNA$128
- VRAYLAR$125
- ABILIFY MAINTENA$125
- Nalu Neurostimulation System$124
- Austedo XR$120
- Fanapt$115
How this compares
$398,488 in reported general payments places this provider in the 95th percentile of 317 child & adolescent psychiatry providers in New York.
See all child & adolescent psychiatry providers in New York →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexmethylphenidate Hcl | 13 | $1,041 |
| Sertraline Hcl | 16 | $276 |
| Alprazolam | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in New York
- Jeffrey NewcornNew York$165K
- Iliyan IvanovNew York$38K
- Melvin OatisNew York$35K
- Alexander KolevzonNew York$10K
- Moira RynnNew York$8K
- Jeremy Veenstra-VanderweeleNew York$7K
- Eric AlceraNew York$6K
- Adam CohenNew York$3K
- Philip VincentNew York$2K
- Shannon DelaneyNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.